ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 193 out of 5176

$1.4M Total Retail Price of All Prescriptions

Rank: 126 out of 5176

420 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 15,056 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

63% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,026 939 1 2
LOVAZA 926 888 2 43
CRESTOR 855 797 3 15
NEXIUM 675 646 4 16
DIOVAN HCT 589 568 5 39
CELEBREX 557 539 6 80
LIDODERM 435 430 7 59
ALENDRONATE SODIUM 393 379 8 18
METFORMIN HCL 348 316 9 7
SYNTHROID 333 322 10 33
CREON 298 279 11 111
TAMSULOSIN HCL 292 281 12 20
ATORVASTATIN CALCIUM 276 270 13 9
LOSARTAN POTASSIUM 262 230 14 14
SIMVASTATIN 235 206 15 1
LOSARTAN-HYDROCHLOROTHIAZIDE 234 232 16 35
ACTOS 229 208 17 85
METOPROLOL SUCCINATE 227 222 18 11
ATENOLOL 200 198 19 12
DONEPEZIL HCL 194 188 20 28
JANUVIA 183 171 21 25
PLAVIX 179 171 22 29
CYMBALTA 177 162 23 90
RANITIDINE HCL 172 164 24 36
LIPITOR 172 166 24 51
AVODART 164 153 26 107
DIOVAN 157 130 27 19
IBANDRONATE SODIUM 151 139 28 211
METOPROLOL TARTRATE 147 126 29 6
ZOLPIDEM TARTRATE 145 142 30 17
CLOPIDOGREL 140 127 31 26
LYRICA 138 130 32 133
HYDROCODONE-ACETAMINOPHEN 134 133 S3 33 27
DEXILANT 130 130 34 118
EVISTA 126 113 35 65
OMEPRAZOLE 120 93 36 3
ISOSORBIDE MONONITRATE ER 114 111 37 44
GLYBURIDE-METFORMIN HCL 112 96 R 38 76
BONIVA 111 111 39 236
GLIMEPIRIDE 108 99 40 37
GLIPIZIDE XL 95 95 41 83
AZITHROMYCIN 90 90 42 42
FUROSEMIDE 90 86 42 8
ZOSTAVAX 89 86 44 219
ENALAPRIL MALEATE 87 77 45 22
VESICARE 86 86 46 210
ADVAIR DISKUS 85 85 47 32
FLECTOR 84 79 48 282
ESCITALOPRAM OXALATE 83 80 49 89
CARVEDILOL 79 77 50 24
SERTRALINE HCL 75 75 51 30
LISINOPRIL 72 70 52 5
MELOXICAM 72 62 52 53
NAMENDA 69 69 54 47
PIOGLITAZONE HCL 67 61 R 55 237
BYSTOLIC 66 66 56 96
POTASSIUM CHLORIDE 66 66 56 34
EXFORGE 66 64 56 126
WARFARIN SODIUM 65 49 59 13
FLUOCINONIDE 65 63 59 165
DIGOXIN 65 65 59 56
VOLTAREN 59 56 62 97
POLYETHYLENE GLYCOL 3350 57 56 63 74
FLUTICASONE PROPIONATE 55 51 64 38
ACTONEL 54 54 65 134
VALSARTAN-HYDROCHLOROTHIAZIDE 53 52 66 292
ROPINIROLE HCL 50 50 67 208
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.